H.B. Fuller Company (FUL) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
16 Apr, 2026Opening remarks and agenda
Meeting commenced virtually at 10 A.M. on April 16, 2026, with shareholders, board members, and auditors present.
Agenda included election of directors, ratification of auditors, and advisory vote on executive compensation.
Board and executive committee updates
Three directors, Daniel L. Florness, Celine C. Martin, and Teresa J. Rasmussen, were nominated for re-election to three-year terms.
All nominated directors were currently serving and recommended by the board.
Shareholder proposals
Three proposals were presented: election of directors, ratification of Ernst & Young as auditors, and an advisory vote on executive compensation.
Partial view of Summaries dataset, powered by Quartr API
Latest events from H.B. Fuller Company
- Q2 2026 saw strong revenue, margin, and EPS growth, with a major medical acquisition announced.FUL
Q2 2026 - Adjusted EBITDA and EPS rose with margin expansion despite a 6.6% organic revenue decline.FULQ1 2026
- Proxy covers director elections, auditor ratification, pay, strong results, and ESG focus.FULProxy Filing
- Votes will be cast for director elections, auditor ratification, and executive pay approval.FULProxy Filing
- Margin and EPS growth achieved through cost actions and acquisitions despite revenue headwinds.FULQ4 2025
- Adjusted EBITDA and EPS grew 5% year-over-year, with margin gains and raised full-year guidance.FULQ2 2025
- Q3 2024 saw 6% EBITDA and 7% EPS growth, led by strong Construction Adhesives results.FULQ3 2024
- Adjusted EPS up 20% and EBITDA up 10% year-over-year, with 2024 guidance raised.FULQ2 2024
- FY24 revenue up 1.6%, margin at 16.6%; 2025 outlook cautious with cost and footprint actions.FULQ4 2024